Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MDM2 | Q00987 | 4/20 | 0.51 |
| ▸ | MDM4 | O15151 | 3/20 | 0.51 |
| ▸ | TP53 | P04637 | 3/20 | 0.51 |
| ▸ | CASP3 | P42574 | 3/20 | 0.48 |
| ▸ | TLR2 | O60603 | 2/20 | 0.44 |
| ▸ | TNF | P01375 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20592813 | 1.00 | MDM2 (0.51) | MDM2MDM4TP53CASP3TLR2 | |
| SCHEMBL20592811 | 1.00 | MDM2 (0.51) | MDM2MDM4TP53CASP3TLR2 | |
| SCHEMBL29352034 | 0.94 | MDM4 (0.54) | MDM2MDM4TP53CASP3TLR2 | |
| SCHEMBL15521126 | 0.94 | MDM4 (0.54) | MDM2MDM4TP53CASP3TLR2 | |
| SCHEMBL8227161 | 0.94 | MDM4 (0.54) | MDM2MDM4TP53CASP3TLR2 | |
| SCHEMBL29362168 | 0.94 | MDM4 (0.54) | MDM2MDM4TP53CASP3TLR2 | |
| SCHEMBL118112 | 0.94 | MDM4 (0.54) | MDM2MDM4TP53CASP3TLR2 | |
| SCHEMBL31248559 | 0.94 | MDM4 (0.54) | MDM2MDM4TP53CASP3TLR2 | |
| SCHEMBL20592524 | 0.91 | MDM2 (0.54) | MDM2MDM4TP53CASP3TLR2 | |
| SCHEMBL20592527 | 0.91 | MDM2 (0.54) | MDM2MDM4TP53CASP3TLR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12577274-B2 | Manufacture of glucagon peptides | BACHEM HOLDING AG (CH) | 2026-03-17 | — | — | US | disclosed |
| EP-4058184-B1 | APPARATUS AND METHOD FOR ITERATIVE POLYMER SYNTHESIS | BACHEM AG (CH) | 2025-06-04 | — | — | EP | disclosed |
| EP-4532531-A1 | PROCESS FOR PREPARING GLUCAGON-LIKE PEPTIDE-1 | ScinoPharm Taiwan, Ltd. (TW) | 2025-04-09 | — | — | EP | disclosed |
| EP-3728304-B1 | SOLID PHASE SYNTHESIS OF ACYLATED PEPTIDES | BACHEM HOLDING AG (CH) | 2025-02-12 | — | — | EP | disclosed |
| CN-114929376-B | Apparatus and method for iterative polymer synthesis | 巴克姆股份公司 | 2024-10-01 | — | — | CN | disclosed |
| CN-111670194-B | Preparation of glucagon peptides | 巴赫姆控股股份公司 | 2024-01-26 | — | — | CN | disclosed |
| US-20230406900-A1 | PROCESS FOR PREPARING GLUCAGON-LIKE PEPTIDE-1 | SCINOPHARM TAIWAN, LTD. (TW) | 2023-12-21 | — | — | US | disclosed |
| WO-2023234860-A1 | PROCESS FOR PREPARING GLUCAGON-LIKE PEPTIDE-1 | SCINOPHARM TAIWAN LTD. (TW) | 2023-12-07 | — | — | WO | disclosed |
| US-20220387958-A1 | APPARATUS AND METHOD FOR ITERATIVE POLYMER SYNTHESIS | BACHEM AG (CH) | 2022-12-08 | — | — | US | disclosed |
| EP-3746466-B1 | MANUFACTURE OF GLUCAGON PEPTIDES | BACHEM AG (CH) | 2022-11-23 | — | — | EP | disclosed |
| CN-115181157-A | Method for preparing disulfide bond-containing polypeptide by solid-liquid phase combination | 湖北健翔生物制药有限公司 | 2022-10-14 | — | — | CN | disclosed |
| EP-4058184-A1 | APPARATUS AND METHOD FOR ITERATIVE POLYMER SYNTHESIS | Bachem AG (CH) | 2022-09-21 | — | — | EP | disclosed |
| EP-3433267-B1 | METHOD FOR PREPARING GLUCAGON-LIKE PEPTIDES | BACHEM HOLDING AG (CH) | 2022-08-24 | — | — | EP | disclosed |
| CN-114929376-A | Apparatus and method for iterative polymer synthesis | 巴克姆股份公司 | 2022-08-19 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220387958-A1 | APPARATUS AND METHOD FOR ITERATIVE POLYMER SYNTHESIS | POLI, PUF60, PCNA | MDM2 3240/4885MDM4 1958/4885TP53 4604/4885 |
| US-20230406900-A1 | PROCESS FOR PREPARING GLUCAGON-LIKE PEPTIDE-1 | GLP1R, IAPP, GCG | MDM2 2682/4885MDM4 3675/4885TP53 3054/4885 |
| US-12577274-B2 | Manufacture of glucagon peptides | IAPP, GLP1R, GCG | MDM2 4043/4885MDM4 4113/4885TP53 490/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.